Chemotherapy, radiation, and therapeutic transplants have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop dermatologic adverse events, which lead to decreased quality of life and inconsistent antineoplastic therapy, both of which may affect clinical outcome. Therefore, attentive dermatological care is critical for the optimization of anticancer therapies.
This course is directed towards Dermatologists, Oncologists, and Oncology Nurses.
Memorial Sloan Kettering Cancer is accredited by the Memorial Sloan Kettering Cancer Center designates this educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.